301 related articles for article (PubMed ID: 33799631)
1. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
[TBL] [Abstract][Full Text] [Related]
2. The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.
Heublein S; Mayr D; Vrekoussis T; Friese K; Hofmann SS; Jeschke U; Lenhard M
PLoS One; 2013; 8(8):e71791. PubMed ID: 23951246
[TBL] [Abstract][Full Text] [Related]
3. The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells.
Yan Y; Liu H; Wen H; Jiang X; Cao X; Zhang G; Liu G
Mol Cell Biochem; 2013 Jun; 378(1-2):1-7. PubMed ID: 23580092
[TBL] [Abstract][Full Text] [Related]
4. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
Yan Y; Jiang X; Zhao Y; Wen H; Liu G
Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
[TBL] [Abstract][Full Text] [Related]
5. MiR-206 inhibits estrogen signaling and ovarian cancer cell migration without affecting GPER.
Boscaro C; Ramaschi GE; Trevisi L; Cignarella A; Bolego C
Life Sci; 2023 Nov; 333():122135. PubMed ID: 37778413
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
7. G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival.
Schüler-Toprak S; Skrzypczak M; Ignatov T; Ignatov A; Ortmann O; Treeck O
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3175-3188. PubMed ID: 32813115
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
9. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Modulation of GPER Expression in Gastric and Colonic Smooth Muscle of Male and Female Non-Obese Diabetic (NOD) Mice: Insights into H3K4me3 and H3K27ac Modifications.
Hixon JC; Rivas Zarete JI; White J; Hilaire M; Muhammad A; Yusuf AP; Adu-Addai B; Yates CC; Mahavadi S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791299
[TBL] [Abstract][Full Text] [Related]
11. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development.
Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G
Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131
[TBL] [Abstract][Full Text] [Related]
12. Activation of G protein coupled estrogen receptor prevents chemotherapy-induced intestinal mucositis by inhibiting the DNA damage in crypt cell in an extracellular signal-regulated kinase 1- and 2- dependent manner.
Chen G; Zeng H; Li X; Liu J; Li Z; Xu R; Ma Y; Liu C; Xue B
Cell Death Dis; 2021 Oct; 12(11):1034. PubMed ID: 34718327
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation.
Gros R; Ding Q; Liu B; Chorazyczewski J; Feldman RD
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C532-40. PubMed ID: 23283935
[TBL] [Abstract][Full Text] [Related]
14. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
15. H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology.
Han N; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245092
[TBL] [Abstract][Full Text] [Related]
16. GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts.
Luo H; Yang G; Yu T; Luo S; Wu C; Sun Y; Liu M; Tu G
Endocr Relat Cancer; 2014 Apr; 21(2):355-69. PubMed ID: 24481325
[TBL] [Abstract][Full Text] [Related]
17. GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells.
Weißenborn C; Ignatov T; Poehlmann A; Wege AK; Costa SD; Zenclussen AC; Ignatov A
J Cancer Res Clin Oncol; 2014 Apr; 140(4):663-71. PubMed ID: 24515910
[TBL] [Abstract][Full Text] [Related]
18. The Selective Estrogen Receptor Modulator Raloxifene Regulates Arginine-Vasopressin Gene Expression in Human Female Neuroblastoma Cells Through G Protein-Coupled Estrogen Receptor and ERK Signaling.
Grassi D; Ghorbanpoor S; Acaz-Fonseca E; Ruiz-Palmero I; Garcia-Segura LM
Endocrinology; 2015 Oct; 156(10):3706-16. PubMed ID: 26200092
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER).
Feldman RD; Ding Q; Hussain Y; Limbird LE; Pickering JG; Gros R
FASEB J; 2016 Jun; 30(6):2086-96. PubMed ID: 26911792
[TBL] [Abstract][Full Text] [Related]
20. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
